Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...

This review seeks to familiarize the readers with RSV rapid antigen-detection tests, describe their performance characteristics and comment on their strengths and weaknesses. The authors will ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

But a test of a neutralizing antibody’s capabilities showed the neutralizing antibodies prompted by Scharffenberger’s ...

All of the people in the study took an RSV test between Oct. 1, 2023, and March 31, 2024, and 1,926 people tested positive. There were 3,275 vaccinated people in the study, as determined by ...

Recent health news highlights include FDA approval for a Johnson & Johnson heart device, Canada's approval of Moderna's RSV ...

Here’s what you need to know. While most people who contract RSV can recover at home, some are sick enough to be admitted to ...

Pediatric RSV off-season outbreaks and positivity rates increased in China during the COVID-19 pandemic, according to study findings.

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV) -- which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

This update highlights pivotal events in the health sector, including FDA approvals for heart devices, RSV vaccine success in ...

The study found higher rates of pneumonia and dyspnea in patients with RSV compared with influenza A or B. Limitations include testing variability and lack of data on immunosuppressive disorders ...

To start, the patient's sample is forced through a device causing the adherence ... The patient's sample is applied to the test, and if RSV proteins are present, they adhere to the antibodies ...